Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

RUMENSIN PREMIX DIN 00412791

Status: Cancelled Post Market
Holder: ELANCO DIVISION ELI LILLY CANADA INC
Molecule: MONENSIN SODIUM

Health Canada record

Active ingredient(s)MONENSIN SODIUM 132.2 G
Dosage formDrug Premix
RouteOral
ScheduleNON-PRESCRIPTION DRUGS
ClassVeterinary
ATC
Original market date31-Dec-1978
Current status date24-Sep-1999
SourceHealth Canada DPD

Establishment licence of the holder

Elanco Division Eli Lilly Canada Inc — licence 101626, not currently licensed, last inspection rating C (2016-06-28).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing MONENSIN SODIUM

DINProductCompanyFormStrengthStatus
00645648HI GAIN FEEDLOT RUMENSIN PREMIX 2904MG/KGFEDERATED COOPERATIVES LTD.Drug PremixMONENSIN SODIUM 2.904 GCancelled Post Market
00858145PREMELANGE 25/2 GRIL MED (COBAN) 7.92GM/KGLA COOP FEDEREEDrug PremixMONENSIN SODIUM 7.92 GCancelled Post Market
01989863PREMELANGE 40/350 RUMENSINLA COOP FEDEREEDrug PremixMONENSIN SODIUM 1 G; VITAMIN A 35000 UNIT; VITAMIN D 3500 UNIT; VITAMIN E 35 UNITCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
68271997-04-25Supplement to a New Drug Submission (SNDS)THE COMPATIBILITY WITH THE THIXOTROPE LIQUID SUPPLEMENT: HCS, NUTRENA FEEDS, CARGILL LIMITED
Request a quote for RUMENSIN PREMIX

How to read a Canadian DIN record